• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量丁丙诺啡治疗美沙酮戒断反应的开放性试验。

An open trial of low dose buprenorphine in treating methadone withdrawal.

作者信息

Banys P, Clark H W, Tusel D J, Sees K, Stewart P, Mongan L, Delucchi K, Callaway E

机构信息

Substance Abuse Programs, VA Medical Center, San Francisco, CA 94121.

出版信息

J Subst Abuse Treat. 1994 Jan-Feb;11(1):9-15. doi: 10.1016/0740-5472(94)90059-0.

DOI:10.1016/0740-5472(94)90059-0
PMID:8201637
Abstract

Buprenorphine (BPN) is a prescription analgesic with mixed opioid agonist and antagonist properties. This pilot study conducted detailed case studies with 15 methadone dependent patients. The study sought to determine whether repeated low doses (0.15 to 0.3 mg) of sublingual BPN would relieve opioid withdrawal symptoms. Subjects developed mild to moderate withdrawal symptoms within 26 to 31 hours of methadone discontinuation. Once in withdrawal, the subjects received 0.15 mg of BPN sublingually. A second dose of 0.15 mg was administered in an hour, and a 0.30 mg dose in 2 hours, if the subject obtained no relief of withdrawal symptoms. In 6 subjects a low dose of 0.15 to 0.30 mg sublingual BPN resulted in the disappearance of subjective and objective withdrawal symptoms within 10 minutes to 2.5 hours. Four others had brief, partial relief of symptoms. Five subjects failed to experience any relief of withdrawal symptoms after a total of 0.6 mg BPN administered over 3 hours. One nonresponder suffered what appeared to be a severe precipitated withdrawal reaction similar to that which can be produced in addicts by a naloxone challenge. The 4 Caucasian responders required 1 to 2 hours to respond to BPN, whereas the 2 African-American responders required only 10 to 20 minutes. Low (analgesic) doses of BPN were sufficient to treat all methadone withdrawal symptoms in 6 of 15 subjects. There may be ethnic differences in response to BPN. Low dose BPN may play a role in carefully monitored heroin detoxification treatment.

摘要

丁丙诺啡(BPN)是一种具有阿片类激动剂和拮抗剂混合特性的处方镇痛药。这项试点研究对15名美沙酮依赖患者进行了详细的案例研究。该研究旨在确定重复低剂量(0.15至0.3毫克)的舌下丁丙诺啡是否能缓解阿片类药物戒断症状。受试者在停用美沙酮后的26至31小时内出现了轻至中度的戒断症状。一旦进入戒断状态,受试者舌下含服0.15毫克丁丙诺啡。如果受试者的戒断症状没有缓解,一小时后给予第二剂0.15毫克,两小时后给予0.30毫克。在6名受试者中,低剂量(0.15至0.30毫克)的舌下丁丙诺啡在10分钟至2.5小时内使主观和客观戒断症状消失。另外4名受试者的症状得到了短暂的部分缓解。5名受试者在3小时内总共服用0.6毫克丁丙诺啡后,戒断症状没有得到任何缓解。一名无反应者出现了似乎是严重的急性戒断反应,类似于纳洛酮激发试验在成瘾者中产生的反应。4名白种人反应者对丁丙诺啡的反应需要1至2小时,而2名非裔美国反应者仅需10至20分钟。低剂量(镇痛剂量)的丁丙诺啡足以治疗15名受试者中的6名的所有美沙酮戒断症状。对丁丙诺啡的反应可能存在种族差异。低剂量丁丙诺啡可能在严格监测的海洛因脱毒治疗中发挥作用。

相似文献

1
An open trial of low dose buprenorphine in treating methadone withdrawal.低剂量丁丙诺啡治疗美沙酮戒断反应的开放性试验。
J Subst Abuse Treat. 1994 Jan-Feb;11(1):9-15. doi: 10.1016/0740-5472(94)90059-0.
2
Treatment of heroin addicts using buprenorphine.使用丁丙诺啡治疗海洛因成瘾者。
Am J Drug Alcohol Abuse. 1991 Jun;17(2):119-28. doi: 10.3109/00952999108992815.
3
A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.海洛因成瘾者和接受美沙酮维持治疗者在戒毒期间戒断反应的比较。
Br J Psychiatry. 1991 May;158:697-9. doi: 10.1192/bjp.158.5.697.
4
Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.丁丙诺啡依赖者阿片类药物戒断症状的评估与管理。
Br J Addict. 1992 Jan;87(1):55-62. doi: 10.1111/j.1360-0443.1992.tb01900.x.
5
Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
Drug Alcohol Depend. 1994 Oct;36(2):139-45. doi: 10.1016/0376-8716(94)90096-5.
6
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.在每日服用100毫克美沙酮维持治疗的受试者中,舌下含服丁丙诺啡/纳洛酮引发了戒断反应。
Drug Alcohol Depend. 2007 Oct 8;90(2-3):261-9. doi: 10.1016/j.drugalcdep.2007.04.006. Epub 2007 May 22.
7
Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.曲马多与丁丙诺啡用于急性海洛因戒断治疗的比较:一项回顾性配对队列对照研究。
Am J Addict. 2006 Mar-Apr;15(2):186-91. doi: 10.1080/10550490500528712.
8
Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.在美沙酮和丁丙诺啡维持治疗期间,可卡因滥用可减轻阿片类药物戒断样症状。
Am J Drug Alcohol Abuse. 1994 Nov;20(4):445-58. doi: 10.3109/00952999409109183.
9
Buprenorphine in opiate withdrawal: a comparison with clonidine.丁丙诺啡用于阿片类药物戒断:与可乐定的比较。
J Subst Abuse Treat. 1993 Jul-Aug;10(4):391-4. doi: 10.1016/0740-5472(93)90024-v.
10
[Depressive disorders in management of drug dependent patients. Methadone maintenance].[药物依赖患者管理中的抑郁症。美沙酮维持治疗]
Encephale. 1995 Dec;21 Spec No 4:11-4.

引用本文的文献

1
Buprenorphine for managing opioid withdrawal.丁丙诺啡用于管理阿片类药物戒断。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.
2
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.丁丙诺啡介导的从阿片类激动剂到拮抗剂治疗的转变:现状与新视角
Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. doi: 10.2174/1874473711205010052.